For: | Wu C, Zhou XM, Liu XD. Eltrombopag-related renal vein thromboembolism in a patient with immune thrombocytopenia: A case report. World J Clin Cases 2021; 9(11): 2611-2618 [PMID: 33889627 DOI: 10.12998/wjcc.v9.i11.2611] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v9/i11/2611.htm |
Number | Citing Articles |
1 |
Eman Mostafa Hamed, Mohamed Hussein Meabed, Ahmed R. N. Ibrahim, Ahmed M. Khalaf, Doaa Mohamed El Demerdash, Marwa O. Elgendy, Haitham Saeed, Tamer M. Mahmoud, Heba F. Salem, Hoda Rabea. Clinical Care Team’s Guide for Awareness on Risk Assessment of Eltrombopag Complicating Acute Kidney Injury in Relapsed Immune Thrombocytopenic Patients: A Case Report. Medicina 2023; 59(9): 1645 doi: 10.3390/medicina59091645
|
2 |
Elrazi A Ali, Maimoonah Rasheed, Anas Al-sadi, Abdalaziz M Awadelkarim, Eltaib A Saad, Mohamed A Yassin. Immune Thrombocytopenic Purpura and Paradoxical Thrombosis: A Systematic Review of Case Reports. Cureus 2022; doi: 10.7759/cureus.30279
|
3 |
|
4 |
Eman Mostafa Hamed, Ahmed R. N. Ibrahim, Mohamed Hussein Meabed, Ahmed M. Khalaf, Doaa Mohamed El Demerdash, Marwa O. Elgendy, Haitham Saeed, Heba F. Salem, Hoda Rabea. The Outcomes and Adverse Drug Patterns of Immunomodulators and Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia Egyptian Patients with Hemorrhage Comorbidity. Pharmaceuticals 2023; 16(6): 868 doi: 10.3390/ph16060868
|